Table of Contents How GLP-1 Medications Affect Gut Health in Women Glucagon-like peptide-1 (GLP-1) receptor agonists, such as semaglutide (Ozempic, Wegovy) and liraglutide (Saxenda, Victoza), are increasingly prescribed for type 2 diabetes management and weight loss
Most available data comes from observational studies, post-hoc analyses, or research focused on metabolic outcomes in patients who happen to have coexisting inflammatory conditions
Combination approaches that couple GSH-triggered release with ferroptosis induction, immunotherapy, radiotherapy, or metabolic modulation represent promising strategies to overcome resistance Fig
Why your stomach is less forgiving than it used to be
Dankort D, Curley DP, Cartlidge RA, Nelson B, Karnezis AN, Damsky WE Jr et al